TiHo Bibliothek elib - Tierärztliche Hochschule Hannover
TiHo Bibliothek elib - Tierärztliche Hochschule Hannover
TiHo Bibliothek elib - Tierärztliche Hochschule Hannover
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Untersuchung des Chemokins MIP-3 β/CCL19<br />
Abstract<br />
Background:<br />
Chemokines are important factors in the mechanism of cell migration and<br />
pathogenesis of central nervous system (CNS) inflammatory reactions. MIP-<br />
3β/CCL19 is one chemokine that may play a major role in this context.<br />
Objective: The aim of this study was to prove the hypothesis that MIP-3β/CCL19 is<br />
involved in the pathogenesis of mononuclear cell migration into the subarachnoid<br />
space of dogs with inflammatory and non-inflammatory CNS diseases such as<br />
steroid-responsive meningitis-arteritis (SRMA) and intervertebral disc disease (IVDD)<br />
and may serve as a valuable biomarker for the progression of the diseases.<br />
Material and methods: This retrospective study analyzed a total of 141 dogs.<br />
Experiments were performed on cerebrospinal fluid (CSF) and peripheral blood (PB)<br />
samples of dogs affected with SRMA during the acute phase (n = 25) as well as<br />
during treatment (n = 26). Dogs with SRMA were compared to dogs with presumed<br />
meningoencephalomyelitis of unknown origin (MUO) receiving no therapy (n = 16)<br />
and with patients receiving prednisolone therapy (n= 11).<br />
A control group with normal cell count consisted of dogs with Idiopathic Epilepsy (IE)<br />
(n= 21) and of healthy dogs (n= 6). Additionally, dogs with IVDD of varying severity<br />
(n= 36) were analyzed. Concentration of MIP-3β/CCL19 in the CSF and serum were<br />
determined by a sandwich ELISA. Migration assays were performed on seven<br />
selected CSF samples using a disposable 96-well chemotaxis chamber (untreated<br />
SRMA n = 3 ; untreated MUO n = 2 ; IVDD n = 2).<br />
Results: MIP-3β/CCL19 was detectable in CSF samples of all dogs. Dogs with<br />
untreated SRMA/MUO displayed pronounced MIP-3β/CCL19 elevations compared to<br />
the control group and patients receiving glucocorticosteroid treatment.<br />
CSF cell count of untreated SRMA/MUO patients was significantly positively<br />
correlated with the MIP-3β/CCL19 CSF concentration. IVDD patients also had<br />
elevated CSF MIP-3β/CCL19 concentration compared to controls, but values were<br />
considerably lower than in inflammatory CNS diseases. Selected CSF samples<br />
including inflammatory and non-inflammatory neurologic diseases displayed<br />
32